Jump to content

Monteplase

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 17:21, 8 December 2020 (Task 18 (cosmetic): eval 2 templates: del empty params (1×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Monteplase is an antithrombic proposed for use in acute myocardial infarction.[1][2]

References

  1. ^ Inoue T, Nishiki R, Kageyama M, Node K (2005). "Therapeutic potential of monteplase in acute myocardial infarction". Am J Cardiovasc Drugs. 5 (4): 225–31. doi:10.2165/00129784-200505040-00002. PMID 15984905.
  2. ^ Inoue T, Nishiki R, Kageyama M, et al. (February 2005). "Long-term benefits of monteplase before coronary angioplasty in acute myocardial infarction". Am. J. Cardiol. 95 (4): 506–8. doi:10.1016/j.amjcard.2004.09.061. PMID 15695140.


Stub icon

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Monteplase&oldid=993072532"